◐ Shell
reader mode source ↗
Jump to content
From Wikipedia, the free encyclopedia
Vaccine candidate against COVID-19

Pharmaceutical compound
AKS-452
Vaccine description
TargetSARS-CoV-2
Vaccine typeProtein subunit
Clinical data
Routes of
administration
Intramuscular
Identifiers
CAS Number

AKS-452 is a COVID-19 vaccine candidate developed by Akston Biosciences.[2][3]

References

[edit]